# Sepsis Fluid Reassessment

After initial crystalloid resuscitation for sepsis-induced hypoperfusion, reassess perfusion, fluid responsiveness, and congestion before each additional bolus. Passive leg raising with stroke-volume or cardiac-output measurement is the most broadly applicable dynamic test; persistent hypotension requires prompt vasopressor support rather than reflexive fluid loading.

**Clinical question:** How should clinicians reassess fluid need after initial crystalloid resuscitation in sepsis-induced hypoperfusion or septic shock?

Updated: 2026-09-15T21:59:43.080762+00:00

## What matters in practice
- Use crystalloid for initial sepsis resuscitation; the Surviving Sepsis Campaign recommendation cited in current reviews is 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock. [8][10][15]
- After the initial bolus, do not use central venous pressure, mean arterial pressure, tachycardia, or other static filling surrogates alone to decide on more fluid; assess a dynamic response to preload and contemporaneous tissue perfusion. [2][4][11]
- Perform passive leg raising with a real-time stroke-volume or cardiac-output readout when feasible; it can be used in spontaneously breathing and mechanically ventilated patients, but abdominal or intracranial hypertension and major hip or lower-extremity trauma limit interpretation or feasibility. [6][18]
- A positive fluid-responsiveness test predicts increased stroke volume or cardiac output after fluid, not necessarily improved outcomes; stop repeated boluses when preload augmentation does not improve flow or when congestion emerges. [11][19]
- For persistent MAP below 65 mm Hg after initial resuscitation, initiate and titrate norepinephrine rather than continuing indiscriminate fluid administration; large peripheral IV access can facilitate early norepinephrine use. [20][21]

## When to reassess after the initial fluid bolus

Reassessment determines whether the next intervention should be fluid, vasopressor, or treatment of another shock mechanism.

For sepsis-induced hypoperfusion or septic shock, give initial IV crystalloid resuscitation promptly; current Surviving Sepsis Campaign guidance cited in contemporary reviews recommends at least 30 mL/kg within 3 hours. Reassess immediately after that initial resuscitation and earlier if respiratory status deteriorates, oxygen requirement rises, or hypotension persists. [10][15][24]

At reassessment, separate three questions: is tissue perfusion still abnormal, will preload augmentation increase cardiac output, and is further fluid likely to worsen edema or pulmonary congestion? Persistent hypotension alone does not establish fluid deficit because septic shock combines vasodilation, capillary leak, and variable myocardial dysfunction. [16][20]

Repeat bedside examination and basic perfusion measures serially, including urine output, capillary refill time, skin temperature gradients, mottling, lactate, blood pressure, and mental status. These measures are sensitive for hypoperfusion but individually have low specificity; integrate them with a dynamic flow assessment before ordering another bolus. [6]
- Recheck lactate when the initial value is at least 2 mmol/L to assess the response to resuscitation. [15]
- Treat MAP below 65 mm Hg or systolic blood pressure below 90 mm Hg as an immediate reassessment trigger; evaluate fluid responsiveness while preparing norepinephrine when hypotension is persistent or severe. [20][21]
- Actively look for a competing or mixed shock state when cardiac output is low, pulmonary edema is present, or the hemodynamic response to preload is absent. [4][14][21]

*Post-bolus reassessment questions and actions in sepsis-induced hypoperfusion. [6][11][20]*

| Question | Bedside assessment | Interpretation | Next action |
| --- | --- | --- | --- |
| Is perfusion still inadequate? | Trend MAP, lactate, urine output, capillary refill, skin temperature gradient, and mottling. [6][15] | Persistent abnormality supports ongoing resuscitation but does not identify fluid as the correct intervention. [6][11] | Perform a dynamic preload test and reassess for vasoplegia, low cardiac output, bleeding, obstruction, or uncontrolled infection. |
| Will fluid increase flow? | Passive leg raise with real-time stroke-volume or cardiac-output measurement; echocardiographic output assessment is reliable. [6][18] | An increase in flow during the maneuver supports fluid responsiveness. [6][18] | If perfusion remains abnormal and no congestion is evident, give a measured crystalloid bolus with immediate repeat assessment. |
| Is vasodilation driving hypotension? | MAP remains below 65 mm Hg or SBP below 90 mm Hg despite initial fluid resuscitation. [20][21] | Additional fluid may not correct pressure when vascular tone is inadequate. [16][20] | Start norepinephrine and titrate to a MAP of at least 65 mm Hg while continuing source-directed sepsis management. [20][21] |
| Should fluids stop? | No flow increase with preload augmentation, rising filling pressures without improved perfusion, or clinical fluid overload. [11][14][17] | Further boluses are unlikely to improve cardiac output and may add harmful extravascular edema. [11][20] | Stop routine boluses; use vasopressor support for hypotension and reassess cardiac function and alternative causes of hypoperfusion. |

## Choose a dynamic test before additional fluid

Dynamic tests estimate whether transient preload augmentation increases stroke volume or cardiac output.

Passive leg raising is the preferred reassessment maneuver when a real-time flow measurement is available. It transiently transfers venous blood from the legs to the central circulation without committing the patient to an administered bolus, and it is feasible in patients with or without invasive mechanical ventilation. Measure stroke volume or cardiac output during the maneuver rather than relying on an isolated pretest value. [6][18]

Transthoracic echocardiography can provide the required flow readout during passive leg raising. Where ultrasound-based output measurement is unavailable, change in pulse pressure or capillary refill time during passive leg raising has shown useful performance, but these alternatives should be interpreted in the full clinical context. [6]

Do not substitute a static central venous pressure, pulmonary capillary wedge pressure, left-ventricular end-diastolic area, MAP, or heart rate for a dynamic fluid-responsiveness assessment. These static indices have limited ability to distinguish fluid responders from nonresponders. [4][11]
- Avoid or qualify passive leg raising in abdominal hypertension, intracranial hypertension, traumatic hip fracture, or lower-extremity fractures. [6]
- Pulse-pressure variation and stroke-volume variation are most applicable during controlled positive-pressure ventilation with sedation, sinus rhythm, and tidal volumes of at least 8 mL/kg; atrial fibrillation, ectopy, spontaneous respiratory effort, and low tidal-volume ventilation reduce reliability. [2][4]
- Inferior vena cava respiratory variation has the same important ventilatory and rhythm-related constraints and should not be interpreted as a stand-alone measure of intravascular volume. [2][4]
- A mini-fluid challenge is an alternative dynamic approach when passive leg raising cannot be performed, provided stroke volume or cardiac output can be measured serially. [6]

### Interpret a positive test correctly

Fluid responsiveness means cardiac output or stroke volume is likely to rise after fluid administration; it does not prove that the patient needs fluid, that organ perfusion will improve, or that outcome will improve. A meta-analysis of four sepsis trials totaling 365 patients found no mortality reduction when fluid resuscitation was managed by fluid responsiveness compared with usual care. [11][19]

Use a positive passive leg raise or other valid dynamic test as permission for a cautious, reassessed crystalloid bolus only when ongoing hypoperfusion is present and the expected benefit exceeds congestion risk. A negative test should redirect treatment toward vasopressors for vasoplegia, echocardiographic assessment for low-output states, and correction of other causes of hypoperfusion. [6][11][20]

*Selection limits of commonly used fluid-responsiveness assessments. [2][4][6]*

| Method | Best-use setting | Important limitation | Clinical use |
| --- | --- | --- | --- |
| Passive leg raise with stroke volume or cardiac output | Spontaneously breathing or mechanically ventilated patient with real-time flow measurement. [6][18] | Limited by abdominal or intracranial hypertension and major hip or lower-extremity trauma. [6] | Preferred reversible preload challenge before another bolus. |
| Pulse-pressure variation or stroke-volume variation | Fully passive, volume-controlled mechanical ventilation, sinus rhythm, and tidal volume at least 8 mL/kg. [2][4] | Unreliable with arrhythmia, spontaneous effort, or low tidal-volume ventilation. [2][4] | Use only when physiologic prerequisites are met. |
| Inferior vena cava variation | Selected mechanically ventilated patients meeting ventilatory prerequisites. [2][4] | Affected by ventilation conditions, tidal volume, and lung compliance; not a universal test. [2][5] | Supportive finding, not a stand-alone fluid order. |
| Static filling surrogates | Readily available but poor discriminators of fluid responsiveness. [4][11] | CVP, PCWP, MAP, tachycardia, and left-ventricular end-diastolic area do not reliably identify responders. [4][11] | Do not use alone to justify repeated fluid loading. |

## Give further fluid only as a monitored intervention

Each bolus should have a defined physiologic target and a predefined stop rule.

Use isotonic crystalloid as the initial resuscitation fluid. Current guidance allows buffered crystalloid or saline; reviews cite data associating buffered solutions with fewer major adverse kidney events through 30 days or hospital discharge in critically ill patients than saline. [8][9]

After initial resuscitation, administer additional fluid as discrete, reassessed boluses rather than an unexamined cumulative volume. In the CLOVERS protocol, rescue crystalloid was administered in 500-mL boluses for severe or refractory hypotension, rising lactate above 4 mmol/L after at least 2 hours of therapy, persistent sinus tachycardia above 130/min for more than 15 minutes, or extreme volume depletion by hemodynamic monitoring. These trial criteria are pragmatic triggers, not universal requirements. [20]

Stop or slow fluids when preload augmentation fails to improve flow, filling pressures rise without improved tissue perfusion, or clinical volume overload develops. The principal tradeoff is that crystalloid may transiently increase intravascular volume while worsening extravascular edema in the lungs and other organs. [11][14][20]
- Consider albumin only when substantial crystalloid volumes are required; avoid synthetic starches for sepsis resuscitation. [22][24]
- Do not treat a positive dynamic test in isolation: require a concurrent resuscitation target such as persistent hypotension, abnormal peripheral perfusion, oliguria, or an unfavorable lactate trend. [6][11][15]
- When the patient has severely reduced cardiac function, end-stage renal disease, or evidence of fluid overload, individualize the initial and subsequent fluid plan and prioritize frequent reassessment. [17]

*Operational stop rules after a post-initial-resuscitation crystalloid bolus. [11][14][20]*

| Finding after preload test or bolus | Meaning | Action |
| --- | --- | --- |
| Improved stroke volume or cardiac output and persistent hypoperfusion without congestion. [6][18] | Fluid responsiveness with a remaining perfusion target. | Consider another measured crystalloid bolus, then repeat perfusion and flow assessment. |
| No increase in stroke volume or cardiac output with passive leg raise or fluid. [6][11] | Patient is unlikely to benefit hemodynamically from further preload. | Stop routine fluids; assess vascular tone and cardiac function. |
| Rising filling pressures without improved tissue perfusion. [14] | Further fluid is unlikely to restore effective perfusion. | Reduce or stop infusion; use alternative hemodynamic support. |
| New or worsening fluid overload. [17][20] | Extravascular fluid accumulation may outweigh any intravascular benefit. | Stop additional boluses and reassess respiratory and cardiac status. |

## Escalate to norepinephrine when pressure remains inadequate

Persistent hypotension after initial fluid is a vasopressor decision, not an automatic indication for more volume.

For MAP below 65 mm Hg or SBP below 90 mm Hg after initial resuscitation, begin norepinephrine and titrate to restore a MAP of at least 65 mm Hg. The CLOVERS protocol targeted MAP from 65 to 75 mm Hg, and early norepinephrine could be administered through a large peripheral IV catheter when central access was not yet available. [20][21]

Use norepinephrine concurrently with dynamic reassessment rather than waiting for an arbitrary fluid volume when hypotension is profound or refractory. Trial protocols permitted rescue fluid for MAP below 50 mm Hg, SBP below 70 mm Hg, or MAP below 65 mm Hg despite norepinephrine at least 20 mcg/min or 0.25 mcg/kg/min in an 80-kg adult; these thresholds identify severe instability requiring immediate reassessment rather than a mandate to continue fluid. [20]

If hypotension persists despite fluid and vasopressor therapy, reassess for low cardiac output and mixed shock. In guideline summaries, dobutamine is reserved for low cardiac output persisting despite fluid resuscitation in the setting of combined inotropic and vasopressor support; echocardiographic assessment should guide this branch rather than empirical inotrope use. [14][21]
- Do not use dopamine routinely; guideline summaries restrict it to highly selected circumstances. [13]
- Vasopressin at 0.03 units/min may be added to norepinephrine to raise MAP or reduce norepinephrine dose, but it should not be the initial vasopressor. [13]
- Continue source control and empiric antimicrobial treatment in parallel; hemodynamic normalization without infection control is not adequate sepsis management. [12][13][14]

*Hemodynamic branch points after initial crystalloid resuscitation. [13][14][20][21]*

| Post-fluid pattern | Likely dominant problem | Immediate action |
| --- | --- | --- |
| MAP below 65 mm Hg with ongoing vasodilatory shock. [20][21] | Inadequate vascular tone. | Start and titrate norepinephrine to MAP at least 65 mm Hg. [20][21] |
| Positive dynamic preload response plus persistent hypoperfusion. [6][18] | Potentially recruitable preload. | Give a measured crystalloid bolus and immediately reassess flow, perfusion, and congestion. |
| Negative dynamic preload response with persistent hypoperfusion. [6][11] | Fluid-unresponsive shock or mixed physiology. | Avoid routine additional fluid; evaluate cardiac output and escalate vasoactive support as indicated. |
| Low cardiac output after fluid resuscitation with persistent shock. [14][21] | Sepsis-associated myocardial dysfunction or mixed cardiogenic physiology. | Perform echocardiographic assessment; consider dobutamine within combined inotrope-vasopressor support when low output persists. [14] |

## Repeat reassessment as physiology changes

Fluid responsiveness and perfusion targets change over minutes to hours during sepsis treatment.

Repeat the same objective measurements after every clinically meaningful intervention: fluid bolus, vasopressor escalation, initiation of mechanical ventilation, or abrupt respiratory deterioration. Serial physical examination and basic observations identify evolving hypoperfusion, while repeated dynamic testing limits unnecessary fluid exposure as preload responsiveness changes. [6][11]

Trend lactate rather than treating a single value as a fluid prescription. Recheck lactate when it is initially at least 2 mmol/L, and interpret an unfavorable trend alongside MAP, peripheral perfusion, urine output, and measured flow. A lactate value above 4 mmol/L that is rising after at least 2 hours of therapy was used as a rescue-fluid trigger in CLOVERS, but it should prompt reassessment of source control, oxygen delivery, vasopressor adequacy, and low-output states as well. [15][20]

Once shock resolves, transition from resuscitation to avoidance of iatrogenic fluid accumulation. Excess resuscitation fluid commonly requires subsequent diuresis after shock resolution, reinforcing the need to stop fluids as soon as perfusion targets are met or further preload no longer improves flow. [20]
- Document the test used to assess fluid responsiveness, the measured response, the perfusion target, and the reason for each additional bolus.
- Reassess before giving fluid for oliguria alone; urine output may reflect kidney injury, venous congestion, vasopressor effects, or persistent systemic hypoperfusion rather than correctable hypovolemia. [6][11]
- When a patient no longer has an active perfusion deficit, do not continue maintenance resuscitation boluses solely because an earlier dynamic test was positive. [11][19]

*Serial monitoring after initial sepsis resuscitation. [6][15][20]*

| Interval or trigger | Repeat measurements | Decision changed |
| --- | --- | --- |
| After initial 30 mL/kg crystalloid. [10][15] | MAP, lactate if initially at least 2 mmol/L, urine output, peripheral perfusion, and dynamic fluid-responsiveness test. [6][15] | Determines whether to give a measured bolus, start vasopressor support, or evaluate mixed shock. |
| After each additional bolus. | Stroke volume or cardiac output response, MAP, peripheral perfusion, and signs of fluid overload. [6][11] | Stops further fluid when flow or perfusion does not improve. |
| After vasopressor initiation or titration. | MAP and tissue-perfusion measures; reassess cardiac output if hypoperfusion persists. [6][20][21] | Distinguishes corrected pressure from persistent low-flow or microcirculatory hypoperfusion. |
| After shock resolution. | Fluid balance and clinical evidence of edema or congestion. [20] | Shifts management away from resuscitation fluids and toward fluid stewardship. |

## References
1. Evaluation of the fluid responsiveness in patients with septic shock by ultrasound plus the passive leg raising test - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0022480417307813
2. Monitoring volume and fluid responsiveness: From static to dynamic indicators - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1521689613000372
3. Analysis of the association between hemodynamic parameters... : Medicine — journals.lww.com — https://journals.lww.com/md-journal/fulltext/2026/01020/analysis_of_the_association_between_hemodynamic.148.aspx
4. Stroke volume variation compared with pulse pressure variation and cardiac index changes for prediction of fluid responsiveness in mechanically ventilated patients - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2090730315000031
5. Comparative Analysis of the Collapsibility Index and Distensibility Index of the Inferior Vena Cava Through Echocardiography with Pulse Pressure Variation That Predicts Fluid Responsiveness in Surgical Patients: An Observational Controlled Trial - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1053077020301294
6. How to monitor cardiovascular function in... : Current Opinion in Critical Care — journals.lww.com — https://journals.lww.com/co-criticalcare/fulltext/2021/06000/how_to_monitor_cardiovascular_function_in_critical.11.aspx
7. Why Has Biomarker-Guided Fluid Resuscitation for... : Critical Care Explorations — journals.lww.com — https://journals.lww.com/ccejournal/fulltext/2025/06000/why_has_biomarker_guided_fluid_resuscitation_for.8.aspx
8. The Surviving Sepsis Campaign: Fluid Resuscitation and ... - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7963440
9. The surviving sepsis campaign: fluid resuscitation and vasopressor ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7917035
10. Fluid Resuscitation in Patients Presenting with Sepsis: Current Insights — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9719278
11. Fluid Management in Sepsis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6532631
12. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/15090974
13. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/23353941
14. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/18058085
15. Early Recognition and Initial Management of Sepsis in Adult Patients — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK598311
16. Septic Shock - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK430939
17. Hospital Sepsis Program Core Elements - CDC — www.cdc.gov — https://www.cdc.gov/sepsis/hcp/core-elements/index.html
18. Is Passive Leg Raise an Accurate Diagnostic Method for Assessing Fluid Responsiveness in Adults? — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(15)01513-9/pdf
19. Outcomes Using Fluid Responsiveness to Manage Fluid Resuscitation - CHEST — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(21)01324-6/fulltext
20. [PDF] Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/28/NCT03434028/Prot_000.pdf
21. [PDF] HCFMUSP The Effect of Non-Invasive Hemodynamic Therapy — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/57/NCT05336357/Prot_SAP_000.pdf
22. [PDF] Effects of restricting intravenous fluids vs. standard care fluid — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/36/NCT03668236/Prot_000.pdf
23. Fluid resuscitation management in patients with burns: update — www.bjanaesthesia.org — https://www.bjanaesthesia.org/article/S0007-0912(17)33788-1/fulltext
24. ClinicalTrials.gov AMENDED CLINICAL STUDY PROTOCOL Applicable for Sites in France only — cdn.clinicaltrials.gov — https://cdn.clinicaltrials.gov/large-docs/48/NCT03158948/Prot_SAP_000.pdf

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.